官司是已经赢了还是估计会赢？

Brad Loncar, biotech investor and creator of two Nasdaq-listed exchange traded funds, told Endpoints News, “I think this was the only remaining hurdle to the deal valuation. I wouldn’t be surprised to see it announced on Monday morning.” $默沙东(MRK)$ 

niuability